Zivadinov has roots in Italy, I wonder if that was how he got into this:
Quote:
Founding Director, Trieste Neuroimaging Analysis Center
Department of Clinical Medicine and Neurology, University of Trieste, Italy
1997 – 2002
Chief Researcher, Multiple Sclerosis
Center for Diagnosis and Treatment of Multiple Sclerosis
Department of Clinical Medicine and Neurology, University of Trieste, Italy
1999 – 2002
Neurologist on Night Guard Duty, 4th Sanitary District “Medio Friuli”
San Pietro al Natisone (Udine), Italy
1999 – 2002
http://www.bnac.net/wp-content/uploads/ ... 6-1-09.pdfA good article about him here:
http://www.nacional.hr/en/clanak/38074/ ... usinessman... although my paranoid side gets worried about his reliance on big pharma dollars ... in my imagination it is plausible that those who stand to lose billions if MS is a vascular condition would organize a well-publicized study that is corrupt, with the goal of discrediting CCSVI in the public eye and burying it ...
Quote:
Robert Zivadinov adds that clinical research is the most profitable area of work his Centre does. "We are a centre that reads the findings of magnetic resonances for multi-centre clinical research, which means that about 100 different centres around the world send us their magnetic resonance shots for our analysis. The analysis and research is done in collaboration with the world's largest pharmaceutical companies who provide massive funding for this kind of research, and that is one of the aspects of the financing of our centre. We currently cooperate with five pharmaceutical companies for whom we are working on five big clinical research programs." Zivadinov points out that pharmaceutical companies are in recent years exceptionally interested for research into mediations for multiple sclerosis. While there were in 2001, he says, only a few such companies, there are currently at least twenty that are launching research linked to multiple sclerosis.
Of course I am aware that this is
pure paranoia at this point! (But if the Italian research looks positive, Dake's stent patients do good, but then this Buffalo study comes back negative, you can bet I'll be letting the paranoia come to the forefront of my mind.
)
Fortunately, I am sure his center will find plenty of profit in workng with the intensive imaging/MRI requirements of this potential new paradigm ...
News 
Site map 
SitemapIndex 
RSS Feed 
Login
Register
FAQ
Search
of the German MS society.
